Tag archive for ‘Exalenz Bioscience Ltd. (TASE:EXEN)’
Globes On Saturday, July 27th, 2013

Exalenz Bioscience raises NIS 28 million ($ 7.7 million) in rights issue

– The company has developed the BreathID device for diagnosis diseases of the digestive tract from a patient’s breath. – / By Gali Weinreb / Exalenz Bioscience Ltd. (TASE:EXEN) completed on More...

Wordpress site Developed by Fixing WordPress Problems